Compugen (NASDAQ:CGEN) Downgraded to Hold Rating by StockNews.com
Compugen (NASDAQ:CGEN – Get Free Report) was downgraded by equities research analysts at StockNews.com from a “buy” rating to a “hold” rating in a note issued to investors on Wednesday. Separately, ...
EuropaWire1h
MATTERHORN Trial Shows Perioperative Immunotherapy Significantly Enhances Survival in Gastric and GEJ Cancer Patients
The MATTERHORN Phase III trial has demonstrated that a perioperative regimen combining AstraZeneca’s Imfinzi (durvalumab) with FLOT chemotherap ...
The Tech Edvocate1h
Top 100 Biotech Companies Revolutionizing Healthcare in 2025
Spread the love Table of Contents Introduction Methodology Top 10 Biotech Giants Rising Stars (11-25) Innovators and ...
The New York Times15h
New York Times - Top Stories
People say they are intimidated by online attacks from President Trump, concerned about harm to their businesses or worried about the safety of their families. 8 min read New Order Seeks to ...
The New York Times20h
New York Times - Top Stories
People say they are intimidated by online attacks from President Trump, concerned about harm to their businesses or worried about the safety of their families. 8 min read Trump Administration LIVE ...
Australian Broadcasting Corporation20h
ABC News
Latest update from the BOM shows cyclone likely to cross close to Moreton Bay ...